Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.

Goodnick PJ, Goldstein BJ.

J Psychopharmacol. 1998;12(3 Suppl B):S5-20. Review.

PMID:
9808077
2.

Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.

Carrasco JL, Sandner C.

Int J Clin Pract. 2005 Dec;59(12):1428-34. Review.

PMID:
16351675
3.

Pharmacokinetics of selective serotonin reuptake inhibitors.

Hiemke C, Härtter S.

Pharmacol Ther. 2000 Jan;85(1):11-28. Review.

PMID:
10674711
4.

[Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability].

Gury C, Cousin F.

Encephale. 1999 Sep-Oct;25(5):470-6. Review. French.

PMID:
10598311
5.

Pharmacokinetics of selective serotonin reuptake inhibitors: clinical relevance.

Catterson ML, Preskorn SH.

Pharmacol Toxicol. 1996 Apr;78(4):203-8. Review.

PMID:
8861776
6.

Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.

Baumann P, Rochat B.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 1:15-21. Review.

PMID:
7622807
7.

Pharmacology and pharmacokinetics of citalopram and other SSRIs.

Baumann P.

Int Clin Psychopharmacol. 1996 Mar;11 Suppl 1:5-11. Review.

PMID:
8732438
9.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Baumann P.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. Review.

PMID:
8968657
10.
11.

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Vaswani M, Linda FK, Ramesh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102. Review.

PMID:
12551730
12.

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

Hyttel J.

Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:19-26. Review.

PMID:
8021435
13.

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.

Hemeryck A, Belpaire FM.

Curr Drug Metab. 2002 Feb;3(1):13-37. Review.

PMID:
11876575
14.

Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors.

Lane RM.

Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:31-61. Review. Erratum in: Int Clin Psychopharmacol 1997 Mar;12(2):126.

PMID:
9032002
15.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
16.

Paroxetine: a review.

Bourin M, Chue P, Guillon Y.

CNS Drug Rev. 2001 Spring;7(1):25-47. Review.

17.
18.

Recent pharmacologic advances in antidepressant therapy for the elderly.

Preskorn SH.

Am J Med. 1993 May 24;94(5A):2S-12S. Review.

PMID:
8503477
19.

Clinical implications of the pharmacology of serotonin reuptake inhibitors.

Warrington SJ.

Int Clin Psychopharmacol. 1992 Oct;7 Suppl 2:13-9. Review.

PMID:
1484174
20.

[Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].

Owens JM, Knight DL, Nemeroff CB.

Encephale. 2002 Jul-Aug;28(4):350-5. French.

PMID:
12232544

Supplemental Content

Support Center